Oruka Stock Is Now Up Nearly 700%. Here's What a $687,000 Insider Sale Could Mean

An Oruka Therapeutics executive sold 9,854 directly held common shares for about $687K at a weighted average price of $69.72 per share on June 15, 2026. The report is a routine insider transaction disclosure and does not provide operational or financial updates. Market impact is likely limited unless part of a broader pattern of insider selling.

Analysis

An Oruka Therapeutics executive sold 9,854 directly held common shares for about $687K at a weighted average price of $69.72 per share on June 15, 2026. The report is a routine insider transaction disclosure and does not provide operational or financial updates. Market impact is likely limited unless part of a broader pattern of insider selling.